Bio
Ruben Y. Luo, PhD, DABCC, FADLM is an Assistant Professor of Pathology at Stanford University and Associate Director of Clinical Chemistry Laboratory at Stanford Health Care. He has been dedicated to innovations in translational laboratory medicine: discovery of novel diagnostic markers and innovation of diagnostic technologies. His research focuses on (1) discovering the clinical diagnostic value of molecular characteristics of protein biomarkers, and (2) developing high-resolution mass spectrometry and label-free optical sensing technologies for characterization and accurate measurement of biomarkers. He completed his clinical chemistry fellowship at University of California San Francisco. Prior to the fellowship, he had several years of work experience in the clinical diagnostic industry. He received his PhD in analytical chemistry from Stanford University, and BS in chemistry from Peking University.
He has been an active member and conference speaker in the international clinical chemistry and mass spectrometry communities, e.g., Association for Diagnostics and Laboratory Medicine (ADLM; formerly American Association for Clinical Chemistry, AACC), American Society for Mass Spectrometry (ASMS), Mass Spectrometry & Advances in Clinical Lab (MSACL). His research awards include 2022 AACC George Grannis Award for Excellence in Research and Scientific Publication, 2021 NACCCA Outstanding Research Award, 2020 American Society for Clinical Pathology (ASCP) “40 Under Forty” Honoree, 2020 AACC Academy’s Distinguished Abstract Award, 2019 and 2020 AACC TDM Best Abstract Awards for Outstanding Research, 2019 AACC Student Poster Contest 1st Place, 2020 AACC Student Poster Contest 2nd Place, and 2018 AACC Hot Topics Invited Speaker. He currently serves as an associate editor of JMSACL and an editorial board member of Scientific Reports.
